Deciphering the Transcriptional Landscape of Human Pluripotent Stem Cell-Derived GnRH Neurons: The Role of Wnt Signaling in Patterning the Neural Fate.

Evolving DNA repair synthetic lethality targets in cancer.

Towards Personalized Management of Ovarian Cancer.

Concept: A randomised multicentre trial of first line chemotherapy comparing three weekly cabazitaxel versus weekly paclitaxel in HER2 negative metastatic breast cancer.

The METTL3 RNA Methyltransferase Regulates Transcriptional Networks in Prostate Cancer.

Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer.

FGF8-FGFR1 signaling regulates human GnRH neuron differentiation in a time- and dose-dependent manner.

Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers.

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.

Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical Trial.

Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted.

High Expression of RECQL Protein in ER-Positive Breast Tumours Is Associated With a Better Survival.

Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.

Untangling the clinicopathological significance of MRE11-RAD50-NBS1 complex in sporadic breast cancers.

The frequency and clinical significance of DNA polymerase beta (POLβ) expression in breast ductal carcinoma in situ (DCIS).